1 |
Rafiq N, Iqbal T, Shahid M, Muhammad F (2014). Hematological and biochemical parameters in Pakistani chronic lymphoblastic leukemia patients. Pak J life Soc Sci, 12, 16-19.
|
2 |
Seiffert M, Schulz A, Ohl S, et al (2010). Soluble CD14 is a novel monocyte derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo. Blood, 116, 4223-30.
DOI
|
3 |
Shanafelt TD (2009). Predicting clinical outcome in CLL. how and why. Hematology Am Soc Hematol Educ Program, 2009, 421-9.
DOI
|
4 |
Sagatys EM, Zhang L (2012). Clinical and laboratory prognostic indicators in chronic lymphocytic leukemia. Cancer Control, 19, 18-25.
DOI
|
5 |
Siegel R, Ma J, Zou Z, Jemal A (2014). Cancer statistics, 2014 CA Cancer J Clin, 64, 9-29.
|
6 |
Vroblova V, Smolej L, Vrbacky F, et al (2009). Biological prognostic markers in chronic lymphocytic leukemia. Acta Medica Hradec Kralove, 52, 3-8
DOI
|
7 |
Wang YH, FanL, Xu W, LiJY (2012). Detection methods of ZAP-70 in chronic lymphocytic leukemia. Clin Exp Med, 12, 69-77.
DOI
|
8 |
Abbott BL (2004). Advances in the diagnosis and treatment of chronic lymphocytic leukemia. Clin Adv Hematol Oncol, 2, 448-54.
|
9 |
Baliakas P, Kanellis G, Stavroyianni N, et al (2013). The role of bone marrow biopsy examination at diagnosis of chronic lymphocytic leukemia: a reappraisal. Leuk Lymphoma, 54, 2377-84.
DOI
|
10 |
D'Arena G, Tarnani M, Rumi C, et al (2007). Prognostic significance of combined analysis of ZAP-70 and CD38 in chronic lymphocytic leukemia. Am J Hematol, 82, 787-91.
DOI
|
11 |
Del Principe MI, Del Poeta G, Buccisano F, et al (2006). Clinical significance of ZAP-70 protein expression in B-cell chronic lymphocytic leukemia. Blood, 108, 853-61.
DOI
|
12 |
Gogia A, Sharma A, Raina V, et al (2013). Prevalence of ZAP-70 and CD38 in Indian chronic lymphocytic leukemia patients. Indian J Cancer, 50, 333-6.
DOI
|
13 |
Dodhy MA, Zafar H, Aslam W (2011). Chronic lymphocytic leukemia: an experience of a decade at a tertiary care hospital. Ann Pak Inst Med Sci, 7, 196-9.
|
14 |
Dohner H, Fischer K, Bentz M, et al (1995). p53 gene deletion predicts for poor survival and non-response to therapy with purine analogs in chronic B-cell leukemias. Blood, 85, 580-9.
|
15 |
El- Sharnouby JA, el-Shakankiri AA, Hendy OM, Ahmed LM, Taha AM (2006). Egypt J Immunol, 13, 69-84.
|
16 |
Gribben JG (2008). Molecular profiling in CLL. Hematology Am Soc Hematol Educ Program, 2008, 444-9.
DOI
|
17 |
Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK (1999). Unmutated Ig V(H) genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood, 94, 1848-54.
|
18 |
Hallek M, Langenmayer I, Nerl C, et al (1999). Elevated serum thymidine kinase levels identify a subgroup at high risk of disease progression in early, nonsmoldering chronic lymphocytic leukemia. Blood, 93, 1732-7.
|
19 |
Junaid A, Rao PN, Adil MM (2011). Chromosomal study for prognostic grouping in chronic lymphocytic leukemia. J Coll Physicians Surg Pak, 21, 19-22.
|
20 |
Kermani IA, Dehdilani M, Dolatkhah R (2007). Chronic lymphocytic leukemia in the recent 10 years and treatment effects of fludarabin. Asian Pacific J Cancer Prev, 8, 367-71.
|
21 |
Khan M, Saif A, Sandler S, Mirrakhimov AE (2014). Idelalisib for the treatment of chronic lymphocytic leukemia. ISRN Oncol, 2014, 931858.
|
22 |
Hallek M, Cheson BD, Catovsky D, et al (2008). A report from the international workshop on chronic lymphocytic leukemia updating the national cancer institute working group 1996 guidelines: Blood, 111, 5446-56
DOI
|
23 |
Li ZJ, Qiu LG, Wu T, et al (2008). The clinical and laboratory features of 263 cases of chronic lymphocytic leukemia. Zhonghua Xue Ye Xue Za Zhi, 29, 300-3.
|
24 |
Crespo M, Bosch F, Villamor N, et al (2003). ZAP-70 Expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia. N Engl J Med, 348, 1764-75.
DOI
|
25 |
Marti GE, Carter P, Abbasi F, et al (2003). B-cell monoclonal lymphocytosis and B-cell abnormalities in the setting of familial B-cell chronic lymphocytic leukemia. Cytometry B Clin Cytom, 52, 1-12.
|
26 |
Moreno C, Montserrat E (2008). New prognostic markers in chronic lymphocytic leukemia. Blood Rev, 22, 211-9.
DOI
|
27 |
Mozaheb Z, Hasanzadeh NazarAbadi MH, Aghaee MA (2012). Chronic lymphocytic leukemia and prognostic factors. Asian Pacific J Cancer Prev, 13, 3009-13.
DOI
|
28 |
Chiorazzi N, Rai KR, Ferrarini M (2005). Chronic lymphocytic leukemia. N Engl J Med, 352, 804-815
DOI
|
29 |
Qi RJ, Zhang PH, Qiu LG, et al (2009). Clinical significance of ZAP-70 protein expression in chronic lymphocytic leukemia/ small lymphocytic lymphoma. Zhonghua Bing Li Xue Za Zhi, 38, 329-32.
|
30 |
Rassenti LZ, Huynh L, Toy TL, et al (2004). ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia N Engl J Med, 351, 893-901.
DOI
ScienceOn
|